Menu Search
Equities

BMP Pharma Trading AG

BMP:STU

BMP Pharma Trading AG

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)5.50
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change+37.50%
  • Beta--
Data delayed at least 15 minutes, as of May 17 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

BMP Pharma Trading AG is a Germany-based holding company engaged in the international trade of pharmaceutical raw materials to pharmaceutical, health-food and nutraceutical industries. Its offers four types of pharmaceutical preparations: herbal and fruit extracts; narcotics, including pemoline, morphine monohydrate and others; food additives, such as L-carnitine, vinpocetine and others, and veterinary products. As of December 31, 2011, the Company's scope of consolidated encompassed B.M.P. Bulk Medicines & Pharmaceuticals GmbH, in which it held a 100%-stake, ALPHA Trading GmbH (100%-stake), B.M.P. Pharma Trading Corporation (100%-stake), and B.M.P. Biotec GmbH, in which the Company held a 51%-stake. Apart from B.M.P. Pharma Trading Corporation, which was based in Nashville in the United States, all subsidiaries were based in Germany.

  • Revenue in EUR (TTM)1.64k
  • Net income in EUR1.57m
  • Incorporated2004
  • Employees45.00
  • Location
    BMP Pharma Trading AGBornbarch 16NORDERSTEDT 22848GermanyDEU
  • Phone+49 406455680
  • Fax+49 4 064556868
  • Websitehttps://www.bmp.ag/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.